Learn More
Medchemexpress LLC Mephenytoin | 50-12-4 | 99.9% | 5 MG

Supplier: Medchemexpress LLC HYB11845MG
Mephenytoin is an anticonvulsant and a substrate for CYP2C19 and CYP2B6. It is for research use only. In preclinical studies, orally administered Mephenytoin reduced maternal weight gain and increased offspring mortality at 200 mg/kg in pregnant Sprague-Dawley CD rats. Additionally, Mephenytoin significantly reduced serum cholesterol and triglyceride levels in mice, suggesting a hypolipidemic effect.
- Anticonvulsant compound.
- Acts as a substrate for CYP2C19 and CYP2B6.
- Reduced maternal weight gain in preclinical studies at higher doses.
- Demonstrated hypolipidemic effect in mice by reducing serum cholesterol and triglyceride levels.
- Intended for research use only.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.